Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 2/27/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Stephen P. Squinto

Wrong Dr. Stephen P. Squinto?

Executive Vice President, Chief G...

Phone: (203) ***-****  
Alexion Pharmaceuticals Inc
352 Knotter Drive
Cheshire , Connecticut 06511
United States

Company Description: Alexion Pharmaceuticals, Inc. (Alexion) is a biopharmaceutical company engaged in the discovery, development and delivery of biologic therapeutic products for the...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • Ph.D.
  • doctorate degree , biochemistry and biophysics
    Loyola University
  • bachelor's degree , chemistry
    Loyola University
  • Ph.D. , Company
  • PhD
  • B.A. , Chemistry
    Loyola University of Chicago
143 Total References
Web References
FreshNews.com | U.S. Tech News Updated Daily!
www.freshnews.com, 20 April 2015 [cached]
Audentes Therapeutics Appoints Stephen Squinto, Ph.D. to its Board of Directors--- SAN FRANCISCO Posted at 5:00 AM Audentes Therapeutics, Inc., a biotechnology company committed to the development and commercialization of gene therapy products for patients with serious, rare diseases, today announced the appointment of Stephen Squinto, Ph.D., to the company's Board of Directors. Dr. Squinto, a co-founder of Alexion Pharmaceuticals, Inc., will serve ... read more
Stephen Squinto, Ph.D., ...
alexionpharma.com, 17 Dec 2014 [cached]
Stephen Squinto, Ph.D., Executive Vice President, Chief Global Operations Officer
Stephen Squinto, Ph.D. is co-founder of Alexion Pharmaceuticals and currently serves as Executive Vice President and Chief Global Operations Officer. Dr. Squinto is responsible for Alexion's Global Quality, Manufacturing and Project Management functions.
Since co-founding Alexion with CEO Leonard Bell in 1992, Dr. Squinto has held several leadership positions guiding the company's research and development programs across the Alexion pipeline, including Executive Vice President, Head of R&D, during which he led the Company's program that resulted in Soliris ® approvals for patients with atypical hemolytic uremic syndrome in the US, European Union and Japan.
Prior to co-founding Alexion, Dr. Squinto held various scientific positions at Regeneron Pharmaceuticals, Inc., focused on drug discovery. He has also served as Assistant Professor of Biochemistry and Molecular Biology at Louisiana State University Medical Center. Dr. Squinto is a prominent researcher in molecular and cellular biology, with more than 70 scientific papers resulting from his work. He also serves on the Board of Directors of the regional Chapter of the Juvenile Diabetes Research Foundation.
Dr. Squinto received a bachelor's degree in chemistry and a doctorate degree in biochemistry and biophysics from Loyola University in Chicago.
Alexion Pharmaceuticals - Management Team
www.alxn.com, 5 July 2013 [cached]
Stephen Squinto, Ph.D. Executive Vice President, Chief Global Operations Officer
...
Stephen Squinto, - Executive Vice President, Chief Global Operations Officer
Stephen Squinto, Ph.D. is co-founder of Alexion Pharmaceuticals and currently serves as Executive Vice President and Chief Global Operations Officer. Dr. Squinto is responsible for Alexion's Global Quality, Manufacturing and Project Management functions.
Since co-founding Alexion with CEO Leonard Bell in 1992, Dr. Squinto has held several leadership positions guiding the company's research and development programs across the Alexion pipeline, including Executive Vice President, Head of R&D, during which he led the Company's program that resulted in Soliris ® approvals for patients with atypical hemolytic uremic syndrome in the US, European Union and Japan.
Prior to co-founding Alexion, Dr. Squinto held various scientific positions at Regeneron Pharmaceuticals, Inc., focused on drug discovery. He has also served as Assistant Professor of Biochemistry and Molecular Biology at Louisiana State University Medical Center. Dr. Squinto is a prominent researcher in molecular and cellular biology, with more than 70 scientific papers resulting from his work. He also serves on the Board of Directors of the regional Chapter of the Juvenile Diabetes Research Foundation.
Dr. Squinto received a bachelor's degree in chemistry and a doctorate degree in biochemistry and biophysics from Loyola University in Chicago.
Health Industry Updates
www.leadershipdirectories.com, 16 Feb 2015 [cached]
Alexion Pharmaceuticals, Inc. announced that Stephen Squinto, PhD, will retire from the company, effective January 1, 2015. He will continue to serve the company as Chair of its newly formed Scientific Advisory Board.
Alexion Announces Planned ...
www.rxir.com, 1 Jan 2015 [cached]
Alexion Announces Planned Retirement of Stephen Squinto, Ph.D., Company Co-Founder and Chief Global Operations Officer, in January 2015. Dr. Squinto to Chair AlexionÂ’s Newly Formed Scientific Advisory Board Starting in January
...
Alexion Announces Planned Retirement of Stephen Squinto, Ph.D., Company Co-Founder and Chief Global Operations Officer, in January 2015. Dr. Squinto to Chair AlexionÂ’s Newly Formed Scientific Advisory Board Starting in January
...
Alexion Announces Planned Retirement of Stephen Squinto, Ph.D., Company Co-Founder and Chief Global Operations Officer, in January 2015. Dr. Squinto to Chair Alexion's Newly Formed Scientific Advisory Board Starting in January
CHESHIRE, Conn.--(BUSINESS WIRE)-- Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced the planned retirement of company co-founder Stephen Squinto, Ph.D., effective January 1, 2015.
Dr. Squinto currently serves as Executive Vice President, Chief Global Operations Officer. He co-founded Alexion in 1992 with Leonard Bell, M.D., the Company's principal founder and current Chairman and Chief Executive Officer. Throughout his tenure, Dr. Squinto has been instrumental in building the Company into a global leader in the development, manufacturing and delivery of biotechnology therapeutics.
Dr. Squinto has held numerous leadership positions at Alexion prior to his current role, including Executive Vice President, Head of Research and Development. While in that role Dr. Squinto led the development of eculizumab for patients with atypical hemolytic uremic syndrome, resulting in a second approved indication for Soliris® (eculizumab) in the United States, Europe and Japan. He also contributed significantly to Alexion's acquisition and further development of asfotase alfa as a potential treatment for patients with hypophosphatasia.
Upon Dr. Squinto's retirement from Alexion on January 1, 2015, he will be the Chair of a newly formed Scientific Advisory Board that will provide strategic input into Alexion's discovery science and pipeline. Dr. Squinto and the Scientific Advisory Board will work directly with Dr. Martin Mackay, Executive Vice President and Global Head of Research and Development.
...
"For the past 22 years, Steve has been a partner in medical innovation, helping to build Alexion from our initial handful of employees to our current multinational footprint with operations serving patients in over 50 countries around the world.
...
I am especially gratified that this opportunity can help us to further accelerate Alexion's development of potential treatments for patients with the greatest need for transformative care," said Dr. Squinto.
...
With Dr. Squinto's retirement, and as part of Alexion's established succession planning, Alexion is pleased to announce the promotion of Ms. Julie O'Neill to the position of Executive Vice President, Global Operations, effective January 1, 2015.
Other People with the name "Squinto":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304